Gian Sberna

A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems

Lisa M. Kaminskas, Victoria M. McLeod, Brian D. Kelly et al. · Nanomedicine Nanotechnology Biology and Medicine · 2011 · 171 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker

Lisa M. Kaminskas, Brian D. Kelly, Victoria M. McLeod et al. · Journal of Controlled Release · 2011 · 133 citations

Pharmacy, Medicinal Chemistry, Pharmaceutics +16

The Amyloid β‐Protein of Alzheimer's Disease Increases Acetylcholinesterase Expression by Increasing Intracellular Calcium in Embryonal Carcinoma P19 Cells

Gian Sberna, Javier Sáez‐Valero, Konrad Beyreuther et al. · Journal of Neurochemistry · 1997 · 127 citations

Life Sciences, Neuroscience, Pharmacology +17

Molecular Isoform Distribution and Glycosylation of Acetylcholinesterase Are Altered in Brain and Cerebrospinal Fluid of Patients with Alzheimer’s Disease

Javier Sáez‐Valero, Gian Sberna, Catriona McLean et al. · Journal of Neurochemistry · 1999 · 108 citations · Full text

Life Sciences, Biochemistry, Neuroscience +15

Acetylcholinesterase Is Increased in the Brains of Transgenic Mice Expressing the C‐Terminal Fragment (CT100) of the β‐Amyloid Protein Precursor of Alzheimer's Disease

Gian Sberna, Javier Sáez‐Valero, Q.-X. Li et al. · Journal of Neurochemistry · 1998 · 102 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17